Novartis cuts uneasy 20-year ties to Roche with $20.7 billion voting stake sale
ZURICH (Reuters) – Novartis AG said on Thursday it would sell its nearly one-third voting stake in Roche back to its cross-town rival for $20.7 billion, disentangling the two competitors that had been linked by the investment for more than two decades.FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, […]
Read more